The Rat Model Market is expected to register a CAGR of 8.4% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Rat Model Market report covers analysis by Model Type (Outbred Rats, Inbred Rats, Knockout or Genetically Modified Rats, Hybrid or Congenic Rats, Conditioned or Surgically Modified Rats, Immunodeficient Rats); Service (Breeding, Cryopreservation, Quarantine, Rederivation, Model in licensing, Genetic Testing, Other Services); Therapeutic Area (Toxicology, Oncology, Immunology and Inflammation, Neurology, Diabetes, Other Therapeutic Areas); Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies); End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs)), , and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.
Purpose of the ReportThe report Rat Model Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Rat Model Market Segmentation
Model Type- Outbred Rats
- Inbred Rats
- Knockout or Genetically Modified Rats
- Hybrid or Congenic Rats
- Conditioned or Surgically Modified Rats
- Immunodeficient Rats
- Breeding
- Cryopreservation
- Quarantine
- Rederivation
- Model in licensing
- Genetic Testing
- Other Services
- Toxicology
- Oncology
- Immunology and Inflammation
- Neurology
- Diabetes
- Other Therapeutic Areas
- CRISPR
- Microinjection
- Embryonic Stem Cell Injection
- Nuclear Transfer
- Other Technologies
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations
Strategic Insights
Rat Model Market Growth Drivers- Concentrate on Natural and Organic Treatments: As the health-consciousness of consumers grows, so does the demand for natural and organic treatments for animals. More and more pet owners seek non-toxic, chemical-free products for their pets, including organic foods, herbal supplements, and natural grooming products. This opens the opportunity for companies that can develop products to these preferences and reach a more eco-conscious and health-focused consumer base.
- Personalized Animal Treatments Development: Personalized treatments, like what researchers are developing in humans, are now being done with animals. Advanced diagnostics and genetic profiling allow veterinarians to design treatment plans for every animal based on their specific health needs. As precision medicine becomes increasingly prevalent, so too will the demand for diagnostics and treatments designed for animals based on their genetic profiles, setting up a growing market niche.
- Investing in Animal Health Startups: Venture capital and other investors are paying attention to animal health ventures, hence increasing innovation. Investments in these little entities are flowing into biological medicines, telemedicine, diagnostic, and pet wellness. All this investment is being channeled into the designs of novel treatments and technologies focused on bringing the newest solutions in animal health forward, from gene therapy to AI-based diagnostic tools, opening up a tremendous opportunity for innovation and growth within the market.
- CRISPR technology adoption for precision models: CRISPR/Cas9 gene-editing technology has led to a revolution in genetic research and has been on the increase with rat models. CRISPR enables precise genome modification of rats to make it possible for scientists to perform experiments on precise functions of particular genes or for the simulation of human diseases. The more targeted and relevant an animal model turns out to be, the higher the demand for its genetically modified variants in biomedical research.
- Integration of Artificial Intelligence in Data Analysis: AI and machine learning are increasingly integrated with rat model-based research to more effectively and accurately analyze data. The integration of AI allows vast amounts of experimental data to be processed and provides predictions about potential outcomes as well as optimized designs for experiments. This will enable the market to move more into data-driven, efficient approaches to preclinical research.
- Growing Collaboration Between Academia and Industry: The relationship between academia and pharmaceutical or biotech companies is gaining momentum. The universities and research institutes are primarily developing new rat models for a particular research need, and industry players are funding and providing expertise for scaling these models for drug development. This partnership increases the pace of development of new therapeutic strategies and requires the development of advanced animal models, such as rats.
- Rising Demand for Alternative Animal Models: Although rat models are still of great importance in preclinical research, the demand for alternative animal models is increasing, as they complement or replace rats in specific areas of research. Models such as mice, zebrafish, and organoids are gaining popularity due to their lower cost, shorter lifespan, or higher relevance to certain disease models. This opens up an opportunity for companies to diversify their offerings and develop new models that complement rat-based research, thus ensuring broader market access.
- Advances in Animal Model Technology: Opportunities to enhance the research process lie in combining cutting-edge technologies such as organ-on-a-chip platforms, bioinformatics, high-throughput screening systems, and rat models. These technologies allow researchers to do more complex and accurate studies for better insights and faster drug development. Companies that combine these technologies with traditional rat models have the opportunity to advance the field with the best-integrated solutions for researchers.
- Expansion in Veterinary Applications: The veterinary applications of rat models are growing as research into animal diseases, vaccines, and treatments is becoming more advanced. For instance, rat models are used in the study of zoonotic diseases, which are diseases that can be transferred between animals and humans, veterinary drug development, and improving livestock health. As the focus on animal health increases and the need for effective veterinary treatments grows, this is a significant opportunity for the rat model market.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Rat Model Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Rat Model Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The major factors driving the Rat Model Market are Concentrate on Natural and Organic Treatments, Personalized Animal Treatments Development, and Investing in Animal Health Startups
The key future trends of the market are CRISPR technology adoption for precision models, Integration of Artificial Intelligence in Data Analysis, and Growing Collaboration Between Academia and Industry
The leading players operating in the Rat Model Market include Charles River Laboratories International, Envigo, Taconic Biosciences, Horizon Discovery Group, genOway, Laboratory Corporation of America Holdings, Transposagen Biopharmaceuticals, Transviragen, Janvier Labs.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on the request are an additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Rat Model Market - By Model Type
1.3.2 Rat Model Market - By Service
1.3.3 Rat Model Market - By Therapeutic Area
1.3.4 Rat Model Market - By Technology
1.3.5 Rat Model Market - By End User
1.3.6 Rat Model Market - By Region
1.3.6.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RAT MODEL MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RAT MODEL MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RAT MODEL MARKET - GLOBAL MARKET ANALYSIS
6.1. RAT MODEL - GLOBAL MARKET OVERVIEW
6.2. RAT MODEL - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. RAT MODEL MARKET - REVENUE AND FORECASTS TO 2028 – MODEL TYPE
7.1. OVERVIEW
7.2. MODEL TYPE MARKET FORECASTS AND ANALYSIS
7.3. OUTBRED RATS
7.3.1. Overview
7.3.2. Outbred Rats Market Forecast and Analysis
7.4. INBRED RATS
7.4.1. Overview
7.4.2. Inbred Rats Market Forecast and Analysis
7.5. KNOCKOUT OR GENETICALLY MODIFIED RATS
7.5.1. Overview
7.5.2. Knockout or Genetically Modified Rats Market Forecast and Analysis
7.6. HYBRID OR CONGENIC RATS
7.6.1. Overview
7.6.2. Hybrid or Congenic Rats Market Forecast and Analysis
7.7. CONDITIONED OR SURGICALLY MODIFIED RATS
7.7.1. Overview
7.7.2. Conditioned or Surgically Modified Rats Market Forecast and Analysis
7.8. IMMUNODEFICIENT RATS
7.8.1. Overview
7.8.2. Immunodeficient Rats Market Forecast and Analysis
8. RAT MODEL MARKET - REVENUE AND FORECASTS TO 2028 – SERVICE
8.1. OVERVIEW
8.2. SERVICE MARKET FORECASTS AND ANALYSIS
8.3. BREEDING
8.3.1. Overview
8.3.2. Breeding Market Forecast and Analysis
8.4. CRYOPRESERVATION
8.4.1. Overview
8.4.2. Cryopreservation Market Forecast and Analysis
8.5. QUARANTINE
8.5.1. Overview
8.5.2. Quarantine Market Forecast and Analysis
8.6. REDERIVATION
8.6.1. Overview
8.6.2. Rederivation Market Forecast and Analysis
8.7. MODEL IN LICENSING
8.7.1. Overview
8.7.2. Model in licensing Market Forecast and Analysis
8.8. GENETIC TESTING
8.8.1. Overview
8.8.2. Genetic Testing Market Forecast and Analysis
8.9. OTHER SERVICES
8.9.1. Overview
8.9.2. Other Services Market Forecast and Analysis
9. RAT MODEL MARKET - REVENUE AND FORECASTS TO 2028 – THERAPEUTIC AREA
9.1. OVERVIEW
9.2. THERAPEUTIC AREA MARKET FORECASTS AND ANALYSIS
9.3. TOXICOLOGY
9.3.1. Overview
9.3.2. Toxicology Market Forecast and Analysis
9.4. ONCOLOGY
9.4.1. Overview
9.4.2. Oncology Market Forecast and Analysis
9.5. IMMUNOLOGY AND INFLAMMATION
9.5.1. Overview
9.5.2. Immunology and Inflammation Market Forecast and Analysis
9.6. NEUROLOGY
9.6.1. Overview
9.6.2. Neurology Market Forecast and Analysis
9.7. DIABETES
9.7.1. Overview
9.7.2. Diabetes Market Forecast and Analysis
9.8. OTHER THERAPEUTIC AREAS
9.8.1. Overview
9.8.2. Other Therapeutic Areas Market Forecast and Analysis
10. RAT MODEL MARKET - REVENUE AND FORECASTS TO 2028 – TECHNOLOGY
10.1. OVERVIEW
10.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
10.3. CRISPR
10.3.1. Overview
10.3.2. CRISPR Market Forecast and Analysis
10.4. MICROINJECTION
10.4.1. Overview
10.4.2. Microinjection Market Forecast and Analysis
10.5. EMBRYONIC STEM CELL INJECTION
10.5.1. Overview
10.5.2. Embryonic Stem Cell Injection Market Forecast and Analysis
10.6. NUCLEAR TRANSFER
10.6.1. Overview
10.6.2. Nuclear Transfer Market Forecast and Analysis
10.7. OTHER TECHNOLOGIES
10.7.1. Overview
10.7.2. Other Technologies Market Forecast and Analysis
11. RAT MODEL MARKET - REVENUE AND FORECASTS TO 2028 – END USER
11.1. OVERVIEW
11.2. END USER MARKET FORECASTS AND ANALYSIS
11.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
11.3.1. Overview
11.3.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
11.4. ACADEMIC AND RESEARCH INSTITUTES
11.4.1. Overview
11.4.2. Academic and Research Institutes Market Forecast and Analysis
11.5. CONTRACT RESEARCH ORGANIZATIONS (CROS)
11.5.1. Overview
11.5.2. Contract Research Organizations (CROs) Market Forecast and Analysis
12. RAT MODEL MARKET REVENUE AND FORECASTS TO 2028 – GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Rat Model Market Overview
12.1.2 North America Rat Model Market Forecasts and Analysis
12.1.3 North America Rat Model Market Forecasts and Analysis - By Model Type
12.1.4 North America Rat Model Market Forecasts and Analysis - By Service
12.1.5 North America Rat Model Market Forecasts and Analysis - By Therapeutic Area
12.1.6 North America Rat Model Market Forecasts and Analysis - By Technology
12.1.7 North America Rat Model Market Forecasts and Analysis - By End User
12.1.8 North America Rat Model Market Forecasts and Analysis - By Countries
12.1.8.1 United States Rat Model Market
12.1.8.1.1 United States Rat Model Market by Model Type
12.1.8.1.2 United States Rat Model Market by Service
12.1.8.1.3 United States Rat Model Market by Therapeutic Area
12.1.8.1.4 United States Rat Model Market by Technology
12.1.8.1.5 United States Rat Model Market by End User
12.1.8.2 Canada Rat Model Market
12.1.8.2.1 Canada Rat Model Market by Model Type
12.1.8.2.2 Canada Rat Model Market by Service
12.1.8.2.3 Canada Rat Model Market by Therapeutic Area
12.1.8.2.4 Canada Rat Model Market by Technology
12.1.8.2.5 Canada Rat Model Market by End User
12.1.8.3 Mexico Rat Model Market
12.1.8.3.1 Mexico Rat Model Market by Model Type
12.1.8.3.2 Mexico Rat Model Market by Service
12.1.8.3.3 Mexico Rat Model Market by Therapeutic Area
12.1.8.3.4 Mexico Rat Model Market by Technology
12.1.8.3.5 Mexico Rat Model Market by End User
12.2. EUROPE
12.2.1 Europe Rat Model Market Overview
12.2.2 Europe Rat Model Market Forecasts and Analysis
12.2.3 Europe Rat Model Market Forecasts and Analysis - By Model Type
12.2.4 Europe Rat Model Market Forecasts and Analysis - By Service
12.2.5 Europe Rat Model Market Forecasts and Analysis - By Therapeutic Area
12.2.6 Europe Rat Model Market Forecasts and Analysis - By Technology
12.2.7 Europe Rat Model Market Forecasts and Analysis - By End User
12.2.8 Europe Rat Model Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Rat Model Market
12.2.8.1.1 Germany Rat Model Market by Model Type
12.2.8.1.2 Germany Rat Model Market by Service
12.2.8.1.3 Germany Rat Model Market by Therapeutic Area
12.2.8.1.4 Germany Rat Model Market by Technology
12.2.8.1.5 Germany Rat Model Market by End User
12.2.8.2 France Rat Model Market
12.2.8.2.1 France Rat Model Market by Model Type
12.2.8.2.2 France Rat Model Market by Service
12.2.8.2.3 France Rat Model Market by Therapeutic Area
12.2.8.2.4 France Rat Model Market by Technology
12.2.8.2.5 France Rat Model Market by End User
12.2.8.3 Italy Rat Model Market
12.2.8.3.1 Italy Rat Model Market by Model Type
12.2.8.3.2 Italy Rat Model Market by Service
12.2.8.3.3 Italy Rat Model Market by Therapeutic Area
12.2.8.3.4 Italy Rat Model Market by Technology
12.2.8.3.5 Italy Rat Model Market by End User
12.2.8.4 Spain Rat Model Market
12.2.8.4.1 Spain Rat Model Market by Model Type
12.2.8.4.2 Spain Rat Model Market by Service
12.2.8.4.3 Spain Rat Model Market by Therapeutic Area
12.2.8.4.4 Spain Rat Model Market by Technology
12.2.8.4.5 Spain Rat Model Market by End User
12.2.8.5 United Kingdom Rat Model Market
12.2.8.5.1 United Kingdom Rat Model Market by Model Type
12.2.8.5.2 United Kingdom Rat Model Market by Service
12.2.8.5.3 United Kingdom Rat Model Market by Therapeutic Area
12.2.8.5.4 United Kingdom Rat Model Market by Technology
12.2.8.5.5 United Kingdom Rat Model Market by End User
12.2.8.6 Rest of Europe Rat Model Market
12.2.8.6.1 Rest of Europe Rat Model Market by Model Type
12.2.8.6.2 Rest of Europe Rat Model Market by Service
12.2.8.6.3 Rest of Europe Rat Model Market by Therapeutic Area
12.2.8.6.4 Rest of Europe Rat Model Market by Technology
12.2.8.6.5 Rest of Europe Rat Model Market by End User
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Rat Model Market Overview
12.3.2 Asia-Pacific Rat Model Market Forecasts and Analysis
12.3.3 Asia-Pacific Rat Model Market Forecasts and Analysis - By Model Type
12.3.4 Asia-Pacific Rat Model Market Forecasts and Analysis - By Service
12.3.5 Asia-Pacific Rat Model Market Forecasts and Analysis - By Therapeutic Area
12.3.6 Asia-Pacific Rat Model Market Forecasts and Analysis - By Technology
12.3.7 Asia-Pacific Rat Model Market Forecasts and Analysis - By End User
12.3.8 Asia-Pacific Rat Model Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Rat Model Market
12.3.8.1.1 Australia Rat Model Market by Model Type
12.3.8.1.2 Australia Rat Model Market by Service
12.3.8.1.3 Australia Rat Model Market by Therapeutic Area
12.3.8.1.4 Australia Rat Model Market by Technology
12.3.8.1.5 Australia Rat Model Market by End User
12.3.8.2 China Rat Model Market
12.3.8.2.1 China Rat Model Market by Model Type
12.3.8.2.2 China Rat Model Market by Service
12.3.8.2.3 China Rat Model Market by Therapeutic Area
12.3.8.2.4 China Rat Model Market by Technology
12.3.8.2.5 China Rat Model Market by End User
12.3.8.3 India Rat Model Market
12.3.8.3.1 India Rat Model Market by Model Type
12.3.8.3.2 India Rat Model Market by Service
12.3.8.3.3 India Rat Model Market by Therapeutic Area
12.3.8.3.4 India Rat Model Market by Technology
12.3.8.3.5 India Rat Model Market by End User
12.3.8.4 Japan Rat Model Market
12.3.8.4.1 Japan Rat Model Market by Model Type
12.3.8.4.2 Japan Rat Model Market by Service
12.3.8.4.3 Japan Rat Model Market by Therapeutic Area
12.3.8.4.4 Japan Rat Model Market by Technology
12.3.8.4.5 Japan Rat Model Market by End User
12.3.8.5 South Korea Rat Model Market
12.3.8.5.1 South Korea Rat Model Market by Model Type
12.3.8.5.2 South Korea Rat Model Market by Service
12.3.8.5.3 South Korea Rat Model Market by Therapeutic Area
12.3.8.5.4 South Korea Rat Model Market by Technology
12.3.8.5.5 South Korea Rat Model Market by End User
12.3.8.6 Rest of Asia-Pacific Rat Model Market
12.3.8.6.1 Rest of Asia-Pacific Rat Model Market by Model Type
12.3.8.6.2 Rest of Asia-Pacific Rat Model Market by Service
12.3.8.6.3 Rest of Asia-Pacific Rat Model Market by Therapeutic Area
12.3.8.6.4 Rest of Asia-Pacific Rat Model Market by Technology
12.3.8.6.5 Rest of Asia-Pacific Rat Model Market by End User
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Rat Model Market Overview
12.4.2 Middle East and Africa Rat Model Market Forecasts and Analysis
12.4.3 Middle East and Africa Rat Model Market Forecasts and Analysis - By Model Type
12.4.4 Middle East and Africa Rat Model Market Forecasts and Analysis - By Service
12.4.5 Middle East and Africa Rat Model Market Forecasts and Analysis - By Therapeutic Area
12.4.6 Middle East and Africa Rat Model Market Forecasts and Analysis - By Technology
12.4.7 Middle East and Africa Rat Model Market Forecasts and Analysis - By End User
12.4.8 Middle East and Africa Rat Model Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Rat Model Market
12.4.8.1.1 South Africa Rat Model Market by Model Type
12.4.8.1.2 South Africa Rat Model Market by Service
12.4.8.1.3 South Africa Rat Model Market by Therapeutic Area
12.4.8.1.4 South Africa Rat Model Market by Technology
12.4.8.1.5 South Africa Rat Model Market by End User
12.4.8.2 Saudi Arabia Rat Model Market
12.4.8.2.1 Saudi Arabia Rat Model Market by Model Type
12.4.8.2.2 Saudi Arabia Rat Model Market by Service
12.4.8.2.3 Saudi Arabia Rat Model Market by Therapeutic Area
12.4.8.2.4 Saudi Arabia Rat Model Market by Technology
12.4.8.2.5 Saudi Arabia Rat Model Market by End User
12.4.8.3 U.A.E Rat Model Market
12.4.8.3.1 U.A.E Rat Model Market by Model Type
12.4.8.3.2 U.A.E Rat Model Market by Service
12.4.8.3.3 U.A.E Rat Model Market by Therapeutic Area
12.4.8.3.4 U.A.E Rat Model Market by Technology
12.4.8.3.5 U.A.E Rat Model Market by End User
12.4.8.4 Rest of Middle East and Africa Rat Model Market
12.4.8.4.1 Rest of Middle East and Africa Rat Model Market by Model Type
12.4.8.4.2 Rest of Middle East and Africa Rat Model Market by Service
12.4.8.4.3 Rest of Middle East and Africa Rat Model Market by Therapeutic Area
12.4.8.4.4 Rest of Middle East and Africa Rat Model Market by Technology
12.4.8.4.5 Rest of Middle East and Africa Rat Model Market by End User
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Rat Model Market Overview
12.5.2 South and Central America Rat Model Market Forecasts and Analysis
12.5.3 South and Central America Rat Model Market Forecasts and Analysis - By Model Type
12.5.4 South and Central America Rat Model Market Forecasts and Analysis - By Service
12.5.5 South and Central America Rat Model Market Forecasts and Analysis - By Therapeutic Area
12.5.6 South and Central America Rat Model Market Forecasts and Analysis - By Technology
12.5.7 South and Central America Rat Model Market Forecasts and Analysis - By End User
12.5.8 South and Central America Rat Model Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Rat Model Market
12.5.8.1.1 Brazil Rat Model Market by Model Type
12.5.8.1.2 Brazil Rat Model Market by Service
12.5.8.1.3 Brazil Rat Model Market by Therapeutic Area
12.5.8.1.4 Brazil Rat Model Market by Technology
12.5.8.1.5 Brazil Rat Model Market by End User
12.5.8.2 Argentina Rat Model Market
12.5.8.2.1 Argentina Rat Model Market by Model Type
12.5.8.2.2 Argentina Rat Model Market by Service
12.5.8.2.3 Argentina Rat Model Market by Therapeutic Area
12.5.8.2.4 Argentina Rat Model Market by Technology
12.5.8.2.5 Argentina Rat Model Market by End User
12.5.8.3 Rest of South and Central America Rat Model Market
12.5.8.3.1 Rest of South and Central America Rat Model Market by Model Type
12.5.8.3.2 Rest of South and Central America Rat Model Market by Service
12.5.8.3.3 Rest of South and Central America Rat Model Market by Therapeutic Area
12.5.8.3.4 Rest of South and Central America Rat Model Market by Technology
12.5.8.3.5 Rest of South and Central America Rat Model Market by End User
13. IMPACT OF COVID-19 PANDEMIC ON GLOBAL RAT MODEL MARKET
13.1 North America
13.2 Europe
13.3 Asia-Pacific
13.4 Rest of the World
14. INDUSTRY LANDSCAPE
14.1. MERGERS AND ACQUISITIONS
14.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
14.3. NEW PRODUCT LAUNCHES
14.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
15. RAT MODEL MARKET, KEY COMPANY PROFILES
15.1. CHARLES RIVER LABORATORIES INTERNATIONAL,
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Products and Services
15.1.4. Financial Overview
15.1.5. SWOT Analysis
15.1.6. Key Developments
15.2. ENVIGO
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Products and Services
15.2.4. Financial Overview
15.2.5. SWOT Analysis
15.2.6. Key Developments
15.3. TACONIC BIOSCIENCES
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Products and Services
15.3.4. Financial Overview
15.3.5. SWOT Analysis
15.3.6. Key Developments
15.4. HORIZON DISCOVERY GROUP
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Products and Services
15.4.4. Financial Overview
15.4.5. SWOT Analysis
15.4.6. Key Developments
15.5. GENOWAY
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Products and Services
15.5.4. Financial Overview
15.5.5. SWOT Analysis
15.5.6. Key Developments
15.6. LABORATORY CORPORATION OF AMERICA HOLDINGS
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Products and Services
15.6.4. Financial Overview
15.6.5. SWOT Analysis
15.6.6. Key Developments
15.7. TRANSPOSAGEN BIOPHARMACEUTICALS
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Products and Services
15.7.4. Financial Overview
15.7.5. SWOT Analysis
15.7.6. Key Developments
15.8. TRANSVIRAGEN
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Products and Services
15.8.4. Financial Overview
15.8.5. SWOT Analysis
15.8.6. Key Developments
15.9. JANVIER LABS
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Products and Services
15.9.4. Financial Overview
15.9.5. SWOT Analysis
15.9.6. Key Developments
15.10. BIOMERE
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Products and Services
15.10.4. Financial Overview
15.10.5. SWOT Analysis
15.10.6. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
1. Charles River Laboratories International,
2. Envigo
3. Taconic Biosciences
4. Horizon Discovery Group
5. genOway
6. Laboratory Corporation of America Holdings
7. Transposagen Biopharmaceuticals
8. Transviragen
9. Janvier Labs
10. Biomere
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For